The consumer health technology sector is on the cusp of one of its most consequential public market moments since the 2021 SPAC boom, but this time with real revenue, real retention, and real business models. The combined pre-IPO valuation of all three exceeds $23 Billion, Oura at ~$11 Billion, WHOOP at $10.1 Billion and Strava at ~$2.2 Billion, making this the largest cluster of consumer health listings since the sector was born.

The global health technology sector has entered a transformative phase characterised by the convergence of continuous biometric monitoring, generative artificial intelligence, and synchronous clinical care. This paradigm shift is most prominently evidenced by the recent strategic expansion of WHOOP, a human performance company that has historically focused on the optimisation of elite athletic performance but is now aggressively repositioning itself as a clinical-grade "Healt